Literature DB >> 25407948

Correlating multidimensional fetal heart rate variability analysis with acid-base balance at birth.

Martin G Frasch1, Yawen Xu, Tamara Stampalija, Lucien D Durosier, Christophe Herry, Xiaogang Wang, Daniela Casati, Andrew Je Seely, Zarko Alfirevic, Xin Gao, Enrico Ferrazzi.   

Abstract

Fetal monitoring during labour currently fails to accurately detect acidemia. We developed a method to assess the multidimensional properties of fetal heart rate variability (fHRV) from trans-abdominal fetal electrocardiogram (fECG) during labour. We aimed to assess this novel bioinformatics approach for correlation between fHRV and neonatal pH or base excess (BE) at birth.We enrolled a prospective pilot cohort of uncomplicated singleton pregnancies at 38-42 weeks' gestation in Milan, Italy, and Liverpool, UK. Fetal monitoring was performed by standard cardiotocography. Simultaneously, with fECG (high sampling frequency) was recorded. To ensure clinician blinding, fECG information was not displayed. Data from the last 60 min preceding onset of second-stage labour were analyzed using clinically validated continuous individualized multiorgan variability analysis (CIMVA) software in 5 min overlapping windows. CIMVA allows simultaneous calculation of 101 fHRV measures across five fHRV signal analysis domains. We validated our mathematical prediction model internally with 80:20 cross-validation split, comparing results to cord pH and BE at birth.The cohort consisted of 60 women with neonatal pH values at birth ranging from 7.44 to 6.99 and BE from -0.3 to -18.7 mmol L(-1). Our model predicted pH from 30 fHRV measures (R(2) = 0.90, P < 0.001) and BE from 21 fHRV measures (R(2) = 0.77, P < 0.001).Novel bioinformatics approach (CIMVA) applied to fHRV derived from trans-abdominal fECG during labor correlated well with acid-base balance at birth. Further refinement and validation in larger cohorts are needed. These new measurements of fHRV might offer a new opportunity to predict fetal acid-base balance at birth.

Entities:  

Mesh:

Year:  2014        PMID: 25407948     DOI: 10.1088/0967-3334/35/12/L1

Source DB:  PubMed          Journal:  Physiol Meas        ISSN: 0967-3334            Impact factor:   2.833


  5 in total

1.  Computer-based intrapartum fetal monitoring and beyond: A review of the 2nd Workshop on Signal Processing and Monitoring in Labor (October 2017, Oxford, UK).

Authors:  Antoniya Georgieva; Patrice Abry; Václav Chudáček; Petar M Djurić; Martin G Frasch; René Kok; Christopher A Lear; Sebastiaan N Lemmens; Inês Nunes; Aris T Papageorghiou; Gerald J Quirk; Christopher W G Redman; Barry Schifrin; Jiri Spilka; Austin Ugwumadu; Rik Vullings
Journal:  Acta Obstet Gynecol Scand       Date:  2019-06-18       Impact factor: 3.636

2.  Early Biomarkers and Intervention Programs for the Infant Exposed to Prenatal Stress.

Authors:  Marta C Antonelli; Martin G Frasch; Mercedes Rumi; Ritika Sharma; Peter Zimmermann; Maria S Molinet; Silvia M Lobmaier
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

3.  Temporal Patterns in Sheep Fetal Heart Rate Variability Correlate to Systemic Cytokine Inflammatory Response: A Methodological Exploration of Monitoring Potential Using Complex Signals Bioinformatics.

Authors:  Christophe L Herry; Marina Cortes; Hau-Tieng Wu; Lucien D Durosier; Mingju Cao; Patrick Burns; André Desrochers; Gilles Fecteau; Andrew J E Seely; Martin G Frasch
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

4.  Decreased neuroinflammation correlates to higher vagus nerve activity fluctuations in near-term ovine fetuses: a case for the afferent cholinergic anti-inflammatory pathway?

Authors:  M G Frasch; M Szynkaruk; A P Prout; K Nygard; M Cao; R Veldhuizen; R Hammond; B S Richardson
Journal:  J Neuroinflammation       Date:  2016-05-10       Impact factor: 8.322

5.  Editorial: Perinatology in the Era of Big Data and Nanoparticles.

Authors:  Martin G Frasch
Journal:  Front Pediatr       Date:  2015-11-05       Impact factor: 3.418

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.